Filing Details
- Accession Number:
- 0001127602-12-014940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-30 16:58:33
- Reporting Period:
- 2012-04-27
- Filing Date:
- 2012-04-30
- Accepted Time:
- 2012-04-30 16:58:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1097264 | Allos Therapeutics Inc | ALTH | Pharmaceutical Preparations (2834) | 541655029 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1489966 | Q Charles Morris | 11080 Circlepoint Road Suite 200 Westminster CO 80020 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-04-27 | 7,970 | $1.81 | 665,323 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares are being sold pursuant to a 10b5-1 plan for Charles Q. Morris in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on April 26, 2012.
Billionaire Hedge Funds
